Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
MDAIthis companySpectral AI, Inc.	$1.55	-4.9×	-6.58×	1.92×	-5.97×	-468.4%	45.4%	-43.8%	-38.5%	132.2%	-197.0%	-26.3%	-1.76×	0.98×	-5.71×	0.94×	0.0%	1	-4.49	2	C
CTSOCytosorbents Corporation	$5.55	-4.92×	6.74×	1.07×	-14.38×	-2821.3%	71.5%	-38.4%	-22.1%	-138.9%	-38.8%	-31.5%	4.93×	-5.25×	-5.45×	2.13×	0.0%	4	-12.29	2	C
ECORelectroCore, Inc.	$7.56	-2.72×	-22.29×	1.19×	-3.46×	-4106.2%	86.8%	-41.1%	-43.6%	817.2%	-171.0%	-21.7%	-5.5×	-0.2×	-22.29×	1.02×	0.0%	3	-14.75	2	C
EQEquillium, Inc.	$1.59	-3.97×	4.98×	0×	-5.06×	-77.1%	0.0%	0.0%	0.0%	-78.3%	-83.3%	-16.0%	0.03×	1.33×	0×	10.32×	0.0%	1	14.51	2	C
IPSCCentury Therapeutics, Inc.	$1.74	-9.04×	0.54×	0.79×	19.64×	85.0%	88.0%	-13.8%	-8.8%	-6.0%	-7.2%	-121.6%	0.27×	-5.3×	0×	5.97×	0.0%	1	-1.94	2	C
KPTIKaryopharm Therapeutics Inc.	$0.04	-0.41×	-0.27×	0.55×	-1.69×	-58773.0%	95.9%	-62.1%	-134.2%	66.9%	-236.6%	-93.6%	-0.8×	-1.15×	-1.98×	1.12×	0.0%	2	-27.45	2	B-
Peer median	—	-3.97×	0.54×	0.79×	-3.46×	-2821.3%	86.8%	-38.4%	-22.1%	-6.0%	-83.3%	-31.5%	0.03×	-1.15×	-1.98×	2.13×	0.0%	2	-12.29	2	—